Study of Drug Production and Quality Control Process in Factories: A Case Study in Tolid Mavade Avallieh Daroupakhsh

Authors

  • Mohammad Torkashvand Fouman Faculty of Engineering, College of Engineering, University of Tehran, Tehran, Iran
  • Atefeh Hasan-Zadeh Fouman Faculty of Engineering, College of Engineering, University of Tehran, Iran

DOI:

https://doi.org/10.24203/ajas.v10i1.6922

Keywords:

Pharmaceutical companies, quality control, Tolid Mavade Avallieh Daroupakhsh

Abstract

Tolid Mavade Avallieh Daroupakhsh Company is known as the largest producer of pharmaceutical active pharmaceutical ingredients in the Middle East and as one of the reputable companies in the field of production of narcotic and non-narcotic products worldwide.In addition to production, this complex has not neglected to consider environmental issues. In this regard, for many years, environmental protection has been seriously on its agenda, and since 2007, with the formation of an independent unit called "Production Support Unit" has followed this path more seriously. The first task of pharmaceutical manufacturers is to ensure the safety and effectiveness of their products. It is important only in the case of continuous quality control methods. For this reason the company has various departments including management, accounting, administrative and commercial affairs, planning manager, technical manager, laundry, warehouse manager, control laboratory, production control, synthesis, formulation, production management, production manager, packaging, coating, Facilities, technical management of warehouse, packaging and active pharmaceutical ingredients. Tests performed by a chemist on active pharmaceutical ingredients and drug quality are performed in a controlled laboratory. Other tasks include quality control and assurance and the development of control methods to ensure and match the production process with good GMP production operations. In the new pharmacy, another task is the responsibility of this department, and that is to ensure the compatibility of biological studies and clinical tests with good laboratory operations GLP and good clinical operations GCP. For example, these operations will be controlled by the quality control and assurance department, and their compliance with GCP, GMP, GLP is confirmed. All of these cases are discussed in detail in this paper.

References

Harbison, C.E., et al., "Scientific and Regulatory Policy Committee Points to Consider: Biological Sample Retention From Nonclinical Toxicity Studies", Toxicologic Pathology, p. 01926233211049156, 2021.

Ajit, C.P., A.M. Bhagwat, and A.P. Chaudhari, "CAPA: An important concept of Quality Assurance in Pharmaceutical Industry", Asian Journal of Research in Chemistry, vol. 14, no. 5, p. 357-362, 2021.

Shaikh, R., et al., "Pharmaceutical cocrystal drug products: an outlook on product development", Trends in pharmacological sciences, vol. 39, no. 12, p. 1033-1048, 2018.

Sabouhi, F., M.S. Pishvaee, and M.S. Jabalameli, "Resilient supply chain design under operational and disruption risks considering quantity discount: A case study of pharmaceutical supply chain", Computers & Industrial Engineering, vol. 8, no. 126, p. 657-672, 2018.

Cunha, S., et al., "Improving drug delivery for Alzheimer’s disease through nose-to-brain delivery using nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ hydrogels", International Journal of Nanomedicine, vol. 16, p. 4373, 2021.

Alqahtani, M.S., "Advances in oral drug delivery", Frontiers in Pharmacology, vol. 12, p. 62, 2021.

Boyd, B.J., et al., "Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems", European Journal of Pharmaceutical Sciences, vol. 137: p. 104967, 2019.

Karagianni, A., M. Malamatari, and K. Kachrimanis, "Pharmaceutical cocrystals: new solid phase modification approaches for the formulation of APIs", Pharmaceutics, vol. 10, no. 1, p. 18, 2018.

Araújo, A.S., et al., "Key Information Related to Quality by Design (QbD) Applications in Analytical Methods Development", Braz. J. Anal. Chem, vol. 8, p. 14-28, 2021.

Achanta, P.S., et al., "Quantum mechanical NMR full spin analysis in pharmaceutical identity testing and quality control", Journal of Pharmaceutical and Biomedical Analysis, vol. 192: p. 113601, 2021.

Dao, H., et al., "Microbial stability of pharmaceutical and cosmetic products", Aaps Pharmscitech, vol. 19, no. 1, p. 60-78, 2018.

Wang, D., et al., "Selecting optimal pharmaceutical excipient formulation from life cycle assessment perspectives: A case study on ibuprofen tablet formulations", Journal of Cleaner Production, vol. 292, p. 126074, 2021.

Molavi, F., M. Barzegar-Jalali, and H. Hamishehkar, "Polyester based polymeric nano and microparticles for pharmaceutical purposes: A review on formulation approaches", Journal of Controlled Release, vol. 320, p. 265-282, 2018.

Downloads

Published

2022-03-01

How to Cite

Torkashvand, M., & Hasan-Zadeh, A. (2022). Study of Drug Production and Quality Control Process in Factories: A Case Study in Tolid Mavade Avallieh Daroupakhsh. Asian Journal of Applied Sciences, 10(1). https://doi.org/10.24203/ajas.v10i1.6922